Table 1_Impact of intrauterine infusion of human umbilical cord blood mononuclear cells on

A prospective cohort study of 134 patients with thin endometrium undergoing frozen embryo transfer between January 2022 and December 2023. The dataset compares reproductive outcomes between a treatment group receiving human umbilical cord blood mononuclear cells (n=35) and a control group (n=99). It was authored by Rui Xing and shared under a CC-BY-4.0 license.

Use Cases

• Compare live birth rates between treatment and control groups based on the reported outcome measures.
• Analyze the association between embryo transfer stage (blastocyst vs. cleavage) and live birth likelihood based on the logistic regression results.
• Study miscarriage rates in patients with thin endometrium based on the reported group-specific percentages.
• Investigate the safety profile of intrauterine cell infusion based on the reported absence of adverse effects.

Strengths

• Includes data from 134 patients, providing a defined cohort size.
• Reports specific outcome percentages, such as a 27.6% live birth rate in the treatment group and 38.5% miscarriage rate.
• Uses multivariable logistic regression analysis, suggesting a structured analytical approach.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 21.3 KB, indicating limited scope.

Provenance

Source

figshare

Collection Method

Prospective cohort study.

Time Range

January 2022 - December 2023

Freshness

Last updated 2026-05-28 06:32:26; freshness should be verified.